CDG
UK
Ip
ACCOUNTS AND ANNUAL REPORT
YEAR ENDED 31 JULY 2022

## 

## 



|O|CHARITY EDNINIISSION<br>FOR Ef/SLANO<br>Ah)O WALES|CHARITY EDNINIISSION<br>FOR Ef/SLANO<br>Ah)O WALES|CHARITY EDNINIISSION<br>FOR Ef/SLANO<br>Ah)O WALES|CHARITY EDNINIISSION<br>FOR Ef/SLANO<br>Ah)O WALES|CHARITY EDNINIISSION<br>FOR Ef/SLANO<br>Ah)O WALES|CHARITY EDNINIISSION<br>FOR Ef/SLANO<br>Ah)O WALES|CHARITY EDNINIISSION<br>FOR Ef/SLANO<br>Ah)O WALES|CHARITY EDNINIISSION<br>FOR Ef/SLANO<br>Ah)O WALES||CDG|UK<br>Receipts and payments|UK<br>Receipts and payments|UK<br>Receipts and payments|UK<br>Receipts and payments|No Df any)<br>1191342<br>accounts|No Df any)<br>1191342<br>accounts|||cc'isa||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||FOrthe periOd<br>from|||Penod start date<br>01/08/2021<br>To|||Penod end date<br>31/07/2022|||||
||||'||||||||||||||||||
|~|||||||~|.|~|~|||||||||||
|||||||||||Unrestricted<br>funds|||Restricted<br>funds|Endowment<br>funds||Total|funds||Last year||
|||||||||||tothe|nearest|E|tothe nearest r.|tothe nearest 5||tothenearestt|||tothenearestE||
|A1 Receipts|||||||||||||||||||||
|Donations|||||||||||19,075||||||19,975||3A97||
|Event income|||||||||||||||||||450||
|Merchandise||sales|||||||||||||||||||
|u|tots||||ross|income||or|||||||||||||
|||||||||AR)|||19,075||||||19,975||3,947||
|A2 Asset|and|||investment|||sales||||||||||||||
|Isee table).|||||||||||||||||||||
||||||||u|oa|||||||||||||
||||||Total||receipts,|||||||-||-|le,075||||
|A3 Pa ments|||||||||||||||||||||
|Event expenses|||||||||||1,249||||||1,249||534||
|Merchandise|||||||||||2,022||||||2,022||||
|Postage||||||||||||||||||||74|
|Insurances||||||||||||336||||||335|||
|Advenising|||||||||||||||||||273||
|Suhscripiions||||||||||||719||||||719|238||
|Dcnallcils|||||||||||||||||||513||
|Telephone<br>and internet||||||||||||||||||50|||
|Bank charges||||||||||||||||||38|||
|||||||Sub total|||||4,993||||||4,993||1,532||
|A4 Asset|and|||investment|||||||||||||||||
|urchases||see|||table||||||||||||||||
|||||||Sub total|||||||||||||||
|||||Total||payments|||||4|903||-||-|4,903||1,832||
|Net of||receiptsl(payments)|||||||||14,172||||||14,172||2,115||
|AS Transfers|||between|||funds|||||||||||||||
|AS Cash|funds|||last year|||end||||||||||||||
|Cash||funds|||this year|||end|||34,502||||||34,502||20,330||





|~||~|~||~|~||~<br>~|~||~|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||Unrestricted||Res||tflctetl|Endowment||
||||||||funds|||funds||funds||
||||||||to nearest 2||to|OeafSSt K||to nearest 2||
|81 Cash funds||||Cosh sl bank!l in hand||||54,052||||||
|||||||||450||||||
||||||Total|cash funds||||||||
|||||(sorss bs|lsocss with rsosipie sod osv moors|||||||||
|||||||sorovllt(s))||||||||
||||||||Unrestricted||Restdcted|||Endowment||
||||||||funds|||funds||funds||
|||||Details|||to nearest 2||to|nearest a||to ossnlst 5||
|82Other|monetary assets|||||||||||||
|||||Details|||Fund to which<br>SSSStbe(oil S||Cost||(optionag|Current value<br>o tional||
|83 Investment||assets||||||||||||
|||||Ds(uris|||Fund <br>asset|to which<br> iu.ion|Cost||(optional)|Current value<br>o<br>iona)||
|84Assets retained for the||||||||||||||
|charity's|own|use||||||||||||
||||||||Fuiid|to which|Amount due|||When dus||
|||||Details|||liabil'|relates||o|iona)|o<br>one l||
|85 Liabilities||||Prolessmoal|fees||Unrestrictw)|||||||
|Signed by one or two trustees on<br>behalf of all the trustees|||||Signature|||Print Name||||Date of<br>a<br>rov|I|
|||||||||Julia Louise Boonnsk||||||
|||||||||||||PAGE 2||
|||||||||||||31/08/2022||








## 

## 

## 

|Objec|t|i|v|es and|Acti|viti|es|||
|---|---|---|---|---|---|---|---|---|---|
||||||||SORP reference|||
|Summary|||ofthe purposes|||of|Para 1.17|To preserve<br>and protect good health for the||
|the charity||||as set out|in its|||public benefit by supporting<br>those affected||
|governing|||document|||||by Congenital<br>Disorders of Glycosylation||
|||||||||and funding<br>research<br>into Congenital||
|||||||||Disorders of Glycosylation<br>and||
|||||||||disseminating<br>all useful results<br>into the||
|||||||||public domain.||
|Summary<br>ofthe main<br>activities<br>in relation to those|||||||Para 1.17and<br>u19|We supported<br>families<br>by keeping<br>them<br>updated<br>with the latest information<br>about||
|purposes|||for the public|||||CDG via our website, our newsletters<br>and||
|benefit,||in|particular,||the|||our online 'Meet the CDG Experts Event'.||
|activities,|||projects or||services|||We updated<br>and reprinted<br>our information||
|identified|||in the accounts.|||||packs for newly diagnosed<br>families. We sent||
|||||||||families merchandise<br>so they could 'go||
|||||||||green' for CDG, on CDG Awareness<br>Day.||
|||||||||We supported<br>research<br>into CDG by setting||
|||||||||up a database of patients and encouraging||
|||||||||families to join. We met with a US based||
|||||||||research company<br>and set up a meeting|with|
|||||||||families interested<br>in participating<br>in their||
|||||||||clinical trial.||
|||||||||We connected<br>with other CDG patient||
|||||||||groups and pledged to sponsor the World||
|||||||||CDG Conference<br>in Portugal. We spoke|at|
|||||||||several events and festivals<br>in the South|of|
|||||||||England<br>about CDG to raise awareness.||
|Statement||||confirming|||Para 1.18|Trustees have received the guidance.||
|whether||the trustees|||have|||||
|had regard||||to the guidance||||||
|issued|by||the Charity|||||||
|Commission||||on public||||||
|benefit||||||||||





|||||SORP reference||||||
|---|---|---|---|---|---|---|---|---|---|
|||||Para 1.38||||||
|Policy on|grant making|||||||||
|||||Para 1.38||||||
|Policy on|social investment|||||||||
|including|program||related|||||||
|investment||||||||||
||||||Members ofour||trustee|board and|medical|
|||||Para 1.38|advisory|board attended||meetings|and gave|
|Contribution||made|by||advice, guidance,||and challenge.|||
|volunteers||||||||||
|Other||||||||||



## 

|Achiev|eme|nts|and Pe|rformance||||
|---|---|---|---|---|---|---|---|
|||||SORP reference||||
||||||~|3 newsletters<br>distributed<br>to families||
|||||||and professionals<br>updating<br>families||
|||||||on latest developments<br>in the world||
|Summary<br>ofthe main<br>achievements<br>ofthe charity,||||Para C20|~|of CDG.<br>'Meet the CDG Experts' event talks||
|identifying|the|difference the||||to 8families.||
|charity's<br>work has made to<br>the circumstances<br>of its|||||~|Celebrated<br>CDG Awareness<br>day with<br>families around the UK on social||
|beneficiaries<br>and|||any wider|||media.||
|benefits to society as a|||||~|Website and other social media||
|whole.||||||platforms<br>kept updated<br>with latest||
|||||||information||
||||||~|On Rare Disease Day we launched||
|||||||the first CDG database of patients|in|
|||||||the UK and encouraged<br>our families||
|||||||to sign up.||
||||||~|Updated<br>our CDG information<br>packs||
|||||||for new families diagnosed<br>with||
|||||||CDG.||
||||||~|We met Glycomine,<br>a US based drug||
|||||||development<br>company<br>online, to||
|||||||encourage<br>interested<br>parents to ask||
|||||||questions<br>and find out more about||
|||||||the upcoming<br>clinical trials<br>in the UK.||
||||||~|We spoke to the audience at 'An||
|||||||Evening<br>with Frank Bruno', about||
|||||||CDG, to raise funds and awareness.||
||||||~|We secured donations<br>from one||
|||||||Page|l 6|









## 

|Financial<br>Review|Financial<br>Review|||||
|---|---|---|---|---|---|
|Review ofthe charity's|||Para 1.21|The charity's assets remained|stable for the|
|financial<br>position at|the end|||period, there was a large excess ofincome||
|ofthe<br>eriod||||over ex enditure.||
|Statement<br>explaining|the||Para 1.22|Reserves are held for future|projects such as|
|policy for holding reserves||||grants for families, research and family||
|statin<br>wh<br>the<br>are|held|||events.||
|Amount<br>of reserves|held||Para 1.22|F34,502||
|Reasons for holding|zero||Para 1.22|N/A||
|reserves||||||
|Details offund materially||in|Para 1.24|N/A||
|deficit||||||
|Explanation<br>of any|||Para 1.23|N/A||
|uncertainties<br>about|the|||||
|charity continuing<br>as a going||||||
|concern||||||



|The charity's<br>principal<br>sources of funds (including|Para 1.47|
|---|---|
|any fundraising)||
|Investment<br>policy and<br>objectives<br>including<br>any|Para 1.46|
|social investment<br>policy||
|adopted||
|A description<br>ofthe principal|Para 1.46|
|risks facing the charity||
|Other||





## 

|Description<br>ofcharity's|||||||||
|---|---|---|---|---|---|---|---|---|
|trusts:|||||||||
|Type of governing<br>document|Para 1.25|Constitution|||||||
|trust deed, ro al charter|||||||||
|How is the charity|Para 1.25|CIO foundation|||||||
|constituted?|||||||||
|(e.g unincorporated|||||||||
|association,<br>CIO)|||||||||
|Trustee selection methods|Para 1.25|Every trustee|appointed||by a resolution||||
|including<br>details of any||passed at a properly||convened||meeting||for|
|constitutional<br>provisions e.g.||the charity trustees.||In|selection,|the charity|||
|election to post or name of||has regard to|the skills,||knowledge||and||
|any person or body entitled||experience needed for|||the effective||||
|to appoint one or more||administration|ofthe|CIO.|||||
|trustees|||||||||



|any person or body entitl<br>to appoint one or more<br>trustees|ed|ed|experience needed <br>administration<br>ofthe|
|---|---|---|---|
|Additional<br>information|(optional)|||
|You ma<br>choose to include further statements|||where relevant about:|
|Policies and procedures<br>adopted<br>for the induction|and|Para 1.51||
|training<br>oftrustees||||
|The charity's<br>organisational<br>structure<br>and any wider||Para 1.51||
|network<br>with which the||||
|charity works||||
|Relationship<br>with any related||Para 1.51||
|parties||||
|Other||||



## 

|Chari|name|||CDG UK|
|---|---|---|---|---|
|Other name the chari|||uses||
|Re istered chari||number||1191342|
|Charity's|principal|address||Meadow Lodge|
|||||Catshill|
|||||Bromsgrove|
|||||Worcestershire|
|||||B61 OJL|





|mes|ofthe charity tru|ofthe charity tru|stees who manage|the charity||||
|---|---|---|---|---|---|---|---|
||Trustee name||Office (ifany)|Dates acted ifnot for whole<br>ear|Name <br>toa|ofperson lor body) entitled<br>ointtrustee<br>ifan||
||Julia Boonnak||Chair|||||
||Will Boonnak||Treasurer|||||
||Chantelle|Dixon|Secretary|||||
|4|Nicole Rourke|||||||
|5|Tim Jardine|||||||
|6||||||||
|7||||||||
|8||||||||
|9||||||||
|10||||||||
|11||||||||
|12||||||||
|13||||||||
|14||||||||
|15||||||||
|16||||||||
|17||||||||
|18||||||||
|19||||||||
|20||||||||





## 

|Description<br>ofthe assets||
|---|---|
|held<br>in this capacity||
|Name and objects ofthe||
|charity on whose behalf|the|
|assets are held and how|this|
|falls within the custodian||
|charity's objects||
|Details ofarrangements|for|
|safe custody and||
|segregation<br>ofsuch assets||
|from the charity's<br>own assets||



## 

|Names an|d addresses ofadv|isers<br>(Optional<br>information)|||
|---|---|---|---|---|
|Type of|Name|Address|||
|adviser|||||
|Name of|chief executive or names ofsenior staff members||(Optional|information)|



## 

## 



|The tru|stees declare th|at they have approve|
|---|---|---|
|Signed|on behalf ofthe|charity's trustees|
||Signature(s)|J Boonnak|
||Full name(s)|Julia Louise Boonnak|
|Position|(eg Secretary,|Chair|
||Chair, etc)||
|||31/08/2022|



